Table 1

SEARCH participant survival characteristics


Set 1
Sets 1 and 2

n = 2,270
n = 4,470

Total time at risk, years
1,3851.47

2,5049.24

Median follow-up, yearsa
7.75
(0.56–10)b
7.45
(0.48–10)b
Median time at risk, years
6.47
(0.10–9.64)b
5.70
(0.03–9.77)b
Median time from diagnosis to study entry, years
0.73
(0.00–8.64)b
1.16
(0.00–9.34)b
Number of deaths
359

637

Annual mortality rate
0.026

0.025

5-year survival rate
0.88
(0.86–0.89)c
0.88
(0.87–0.89)c
Median age at diagnosis, years
50.2
(25–69)b
51.0
(23–69)b
Age at diagnosis, years




     <40
212
9.30%
394
8.81%
     40–49
753
33.20%
1,331
29.78%
     50–59
997
43.90%
1,802
40.31%
     60+
308
13.60%
943
21.10%
Histopathological grade




     Well differentiated
434
19.11%
871
19.49%
     Moderately differentiated
787
34.67%
1,687
37.74%
     Poorly differentiated
504
22.20%
1,019
22.80%
     Unknown
545
24.00%
893
19.98%
Morphological type




     Ductal
1,674
73.74%
3,316
74.18%
     Lobular
351
15.46%
659
14.74%
     Other
222
9.78%
455
10.17%
     Unknown
23
1.01%
40
0.89%
Clinical stage




     1
1,112
48.99%
2,190
48.99%
     2
986
43.33%
1,981
44.32%
     3 or 4
172
7.58%
194
4.34%
     Missing
0
0%
105
2.35%

aFollow-up censored at 10 years. bRange of variable. c95% confidence interval. SEARCH, Studies of Epidemiology and Risk factors in Cancer Heredity.

Azzato et al. Breast Cancer Research 2008 10:R47   doi:10.1186/bcr2100